ClearLLab LS

The ClearLLab LS (Lymphoid Screen) reagent is intended for in vitro diagnostic use as a screening panel for identification of various hematolymphoid cell populations by immunophenotyping on an Navios flow cytometer. The antigen specificity of the CD45, CD3, CD4, CD8, CD56 and CD5 monoclonal antibodies has been previously established by the First (CD4, CD8 and CD3), Third (CD5 and CD45),and Fourth (CD56) International Workshop for Leukocyte Typing. The antigen specificity of the CD20, CD19, CD10 and CD34 monoclonal antibodies has been previously established by the Human Leukocyte Differentiation Antigen Workshops. The application of Kappa and Lambda light chain analysis for immunophenotyping B lymphopoetic malignancies has been previously described in the flow cytometric immunophenotyping for hematologic neoplasms.